Plasmidsaurus launched an ultrafast RNA‑Seq service for Illumina short‑read workflows promising sample‑to‑analyzed‑data in as little as three days and simplified inputs (crude cell preps, room‑temperature shipping). The company positioned the service for rapid feedback needs in cell‑line QC, genome‑editing validation and drug‑candidate screening, stressing turnkey analytics so users need not employ in‑house bioinformatics teams. Early access users cited speed and convenience benefits; Plasmidsaurus added new RNA offerings to recent rapid microbiome and AAV sequencing services as part of an overall lab expansion. For readers: rapid, low‑input RNA‑Seq lowers turnaround bottlenecks in preclinical pipelines and can accelerate go/no‑go decisions in lead optimization and cell‑engineering programs.